These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12201871)

  • 61. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study.
    Wang Q; Zheng D; Liu J; Fang L; Li Q
    Lipids Health Dis; 2018 Dec; 17(1):284. PubMed ID: 30545385
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background.
    Kojima S; Watanabe N; Numata M; Ogawa T; Matsuzaki S
    J Gastroenterol; 2003; 38(10):954-61. PubMed ID: 14614602
    [TBL] [Abstract][Full Text] [Related]  

  • 64. BMI history and risk of incident fatty liver: a population-based large-scale cohort study.
    Hashimoto Y; Hamaguchi M; Fukuda T; Nakamura N; Ohbora A; Kojima T; Fukui M
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1188-93. PubMed ID: 27347789
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels.
    Shen Z; Li Y; Yu C; Shen Y; Xu L; Xu C; Xu G
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):820-5. PubMed ID: 19829121
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.
    Li H; Wang YJ; Tan K; Zeng L; Liu L; Liu FJ; Zhou TY; Chen EQ; Tang H
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):377-82. PubMed ID: 19666406
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Overweight Japanese with body mass indexes of 23.0-24.9 have higher risks for obesity-associated disorders: a comparison of Japanese and Mongolians.
    Shiwaku K; Anuurad E; Enkhmaa B; Nogi A; Kitajima K; Shimono K; Yamane Y; Oyunsuren T
    Int J Obes Relat Metab Disord; 2004 Jan; 28(1):152-8. PubMed ID: 14557832
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.
    Hashimoto Y; Hamaguchi M; Fukuda T; Ohbora A; Kojima T; Fukui M
    Endocrine; 2017 Jul; 57(1):89-97. PubMed ID: 28508194
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study.
    Lonardo A; Loria P; Leonardi F; Borsatti A; Neri P; Pulvirenti M; Verrone AM; Bagni A; Bertolotti M; Ganazzi D; Carulli N;
    Dig Liver Dis; 2002 Mar; 34(3):204-11. PubMed ID: 11990393
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Physical activity as a protective factor for development of non-alcoholic fatty liver in men.
    Pinto CG; Marega M; Carvalho JA; Carmona FG; Lopes CE; Ceschini FL; Bocalini DS; Figueira Junior AJ
    Einstein (Sao Paulo); 2015; 13(1):34-40. PubMed ID: 25993066
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup.
    Yamada T; Fukatsu M; Suzuki S; Wada T; Yoshida T; Joh T
    J Gastroenterol Hepatol; 2010 Feb; 25(2):352-6. PubMed ID: 19817963
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index.
    Alatalo PI; Koivisto HM; Hietala JP; Puukka KS; Bloigu R; Niemelä OJ
    Am J Clin Nutr; 2008 Oct; 88(4):1097-103. PubMed ID: 18842799
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Non-alcoholic fatty liver disease among visitors to a hepatitis awareness programme.
    Abbas Z; Saeed A; Hassan SM; Luck NH; Khan A; Zafar MN; Hossain KZ; Faiq SM
    Trop Gastroenterol; 2013; 34(3):153-8. PubMed ID: 24851524
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship between serum TSH level with obesity and NAFLD in euthyroid subjects.
    Zhang J; Sun H; Chen L; Zheng J; Hu X; Wang S; Chen T
    J Huazhong Univ Sci Technolog Med Sci; 2012 Feb; 32(1):47-52. PubMed ID: 22282244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increase in the skeletal muscle mass to body fat mass ratio predicts the decline in transaminase in patients with nonalcoholic fatty liver disease.
    Mizuno N; Seko Y; Kataoka S; Okuda K; Furuta M; Takemura M; Taketani H; Hara T; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Itoh Y
    J Gastroenterol; 2019 Feb; 54(2):160-170. PubMed ID: 29948305
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development and validation of a simple index system to predict nonalcoholic fatty liver disease.
    Park YJ; Lim JH; Kwon ER; Kim HK; Jung MC; Seol KH; Noh WY; Kim NE
    Korean J Hepatol; 2011 Mar; 17(1):19-26. PubMed ID: 21494074
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum Fatty Acid Binding Protein 4 Concentrations Are Positively and Independently Associated with Blood Pressure and Abdominal Fat among Parameters in Health Check-Ups in Ordinary Middle-Aged Japanese Males.
    Yamada M; Mochizuki K; Honma K; Miyauchi R; Kasezawa N; Tohyama K; Goda T
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(4):291-8. PubMed ID: 26440635
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease.
    Abangah G; Yousefi A; Asadollahi R; Veisani Y; Rahimifar P; Alizadeh S
    Iran Red Crescent Med J; 2014 Jan; 16(1):e12669. PubMed ID: 24719704
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum gamma-glutamyl transpeptidase levels and hypertension in non-drinkers: a possible role of fatty liver in the pathogenesis of obesity related hypertension.
    Ikai E; Noborizaka Y; Tsuritani I; Honda R; Ishizaki M; Yamada Y
    Obes Res; 1993 Nov; 1(6):469-74. PubMed ID: 16350321
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus.
    Wu MJ; Fang QL; Zou SY; Zhu Y; Lu W; Du X; Shi BM
    World J Clin Cases; 2021 Sep; 9(26):7717-7728. PubMed ID: 34621822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.